tiprankstipranks
Trending News
More News >
Inhibikase Therapeutics (IKT)
NASDAQ:IKT

Compare Inhibikase Therapeutics (IKT) vs. Competitors

Compare
187 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Inhibikase Therapeutics
$1.56
$189.18M
-2.77
-32.19%
5 Buy
0 Hold
0 Sell
Strong Buy
Atossa Therapeutics
$5.29
$45.55M
-1.51
-58.18%
4 Buy
0 Hold
0 Sell
Strong Buy
Anixa Biosciences
$3.16
$97.47M
-8.17
-8.33%
1 Buy
0 Hold
0 Sell
Moderate Buy
Spero Therapeutics
$2.29
$129.02M
162.26%
0 Buy
2 Hold
0 Sell
Hold
Surrozen
$21.25
$202.71M
-0.97
87.72%
3 Buy
0 Hold
0 Sell
Strong Buy
TScan Therapeutics
$0.96
$54.56M
-0.81
-62.86%
4 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IKT
Inhibikase Therapeutics
1.58
-0.85
-34.98%
ATOS
Atossa Therapeutics
5.33
-6.74
-55.86%
ANIX
Anixa Biosciences
2.75
-0.44
-13.79%
SPRO
Spero Therapeutics
2.30
1.44
167.44%
SRZN
Surrozen
21.25
10.15
91.44%
TCRX
TScan Therapeutics
0.91
-1.46
-61.60%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts